BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Xia F, Wu LL, Lau WY, Huan HB, Wen XD, Ma KS, Li XW, Bie P. Adjuvant sorafenib after heptectomy for Barcelona Clinic Liver Cancer-stage C hepatocellular carcinoma patients. World J Gastroenterol 2016; 22(23): 5384-5392 [PMID: 27340354 DOI: 10.3748/wjg.v22.i23.5384]
URL: https://www.wjgnet.com/1007-9327/full/v22/i23/5384.htm
Number Citing Articles
1
Ai Shen, Miao Liu, Daofeng Zheng, Qingsong Chen, Zhongjun Wu. Adjuvant transarterial chemoembolization after curative hepatectomy for hepatocellular carcinoma with microvascular invasion: A systematic review and meta-analysisClinics and Research in Hepatology and Gastroenterology 2020; 44(2): 142 doi: 10.1016/j.clinre.2019.06.012
2
Ao Huang, Xin-Rong Yang, Wen-Yuan Chung, Ashley R. Dennison, Jian Zhou. Targeted therapy for hepatocellular carcinomaSignal Transduction and Targeted Therapy 2020; 5(1) doi: 10.1038/s41392-020-00264-x
3
Faryal Mehwish Awan, Anam Naz, Ayesha Obaid, Aqsa Ikram, Amjad Ali, Jamil Ahmad, Abdul Khaliq Naveed, Hussnain Ahmed Janjua. MicroRNA pharmacogenomics based integrated model of miR-17-92 cluster in sorafenib resistant HCC cells reveals a strategy to forestall drug resistanceScientific Reports 2017; 7(1) doi: 10.1038/s41598-017-11943-1
4
Xiao-Dong Zhu, Hui-Chuan Sun. Emerging agents and regimens for hepatocellular carcinomaJournal of Hematology & Oncology 2019; 12(1) doi: 10.1186/s13045-019-0794-6
5
Masataka Amisaki, Hiroaki Saito, Naruo Tokuyasu, Teruhisa Sakamoto, Soichiro Honjo, Yoshiyuki Fujiwara. Prognostic value of postoperative complication for early recurrence after curative resection of hepatocellular carcinomaHepatobiliary & Pancreatic Diseases International 2018; 17(4): 323 doi: 10.1016/j.hbpd.2018.03.016
6
Shenglan Huang, Dan Li, LingLing Zhuang, Liying Sun, Jianbing Wu. A meta-analysis of the efficacy and safety of adjuvant sorafenib for hepatocellular carcinoma after resectionWorld Journal of Surgical Oncology 2021; 19(1) doi: 10.1186/s12957-021-02280-9
7
Wenkai Ni, Shiqing Zhang, Bo Jiang, Runzhou Ni, Mingbing Xiao, Cuihua Lu, Jinxia Liu, Lishuai Qu, Hongbing Ni, Wenwen Zhang, Pinghong Zhou. Identification of cancer-related gene network in hepatocellular carcinoma by combined bioinformatic approach and experimental validationPathology - Research and Practice 2019; 215(6): 152428 doi: 10.1016/j.prp.2019.04.020
8
Qingli Li, Tianqiang Song. Association Between Adjuvant Sorafenib and the Prognosis of Patients With Hepatocellular Carcinoma at a High Risk of Recurrence After Radical ResectionFrontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.633033
9
Wang Gu, Zhong Tong. Sorafenib in the treatment of patients with hepatocellular carcinoma (HCC) and microvascular infiltration: a systematic review and meta-analysisJournal of International Medical Research 2020; 48(8): 030006052094687 doi: 10.1177/0300060520946872
10
John R. Bergquist, Amy Y. Li, Christopher S. Javadi, Byrne Lee, Jeffrey A. Norton, George A. Poultsides, Monica M. Dua, Brendan C. Visser. Regional lymph node sampling in hepatoma resection: insight into prognosisHPB 2021; 23(9): 1360 doi: 10.1016/j.hpb.2021.01.006
11
Wei Zhang, Bixiang Zhang, Xiao-ping Chen. Adjuvant treatment strategy after curative resection for hepatocellular carcinomaFrontiers of Medicine 2021; 15(2): 155 doi: 10.1007/s11684-021-0848-3
12
Quanyou Gong, Zhaoxia Qin, Fangli Hou. Improved treatment of early small hepatocellular carcinoma using sorafenib in combination with radiofrequency ablationOncology Letters 2017;  doi: 10.3892/ol.2017.7174
13
Han Ah Lee, Chai Hong Rim. Efficacy of Local Treatments for Hepatocellular Carcinoma Involving the Inferior Vena Cava and/or Right AtriumJournal of Hepatocellular Carcinoma 2020; : 435 doi: 10.2147/JHC.S285357
14
Ana I. Álvarez-Mercado, Albert Caballeria-Casals, Carlos Rojano-Alfonso, Jesús Chávez-Reyes, Marc Micó-Carnero, Alfredo Sanchez-Gonzalez, Araní Casillas-Ramírez, Jordi Gracia-Sancho, Carmen Peralta. Insights into Growth Factors in Liver Carcinogenesis and Regeneration: An Ongoing Debate on Minimizing Cancer Recurrence after Liver ResectionBiomedicines 2021; 9(9): 1158 doi: 10.3390/biomedicines9091158
15
Hiroto Matsui Matsui, Shoichi Hazama, Masao Nakajima, Ming Xu, Satoshi Matsukuma, Yukio Tokumitsu, Yoshitaro Shindo, Shinobu Tomochika, Shin Yoshida, Michihisa Iida, Nobuaki Suzuki, Shigeru Takeda, Shigefumi Yoshino, Tomio Ueno, Masaaki Oka, Hiroaki Nagano. Novel adjuvant dendritic cell therapy with transfection of heat-shock protein 70 messenger RNA for patients with hepatocellular carcinoma: a phase I/II prospective randomized controlled clinical trialCancer Immunology, Immunotherapy 2021; 70(4): 945 doi: 10.1007/s00262-020-02737-y